ALZN
Alzamend Neuro, Inc. · NASDAQ:ALZN
1.25 USD0.0400 +3.31%
Alzamend Neuro, Inc. (NASDAQ:ALZN) last traded at 1.25 USD, up 3.31% on the day. Over the past year the stock is down 53.01%. Its 52-week range is 0.8400 to 2.61. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open1.32
Day range1.21 – 1.33
52-week range0.8400 – 2.61
Volume37.06 K
Average volume (10 days)19.96 K
Market cap6.03 M
EPS (TTM)−2.29
Dividend yield0.00%
Beta (1 year)2.88
Revenue (TTM)0
Employees6
Performance
+13.64%1 week
−11.35%1 month
−9.42%3 months
+16.82%6 months
−32.07%Year to date
−53.01%1 year
Technical reading
Bearish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Alzamend Neuro regains Nasdaq complianceSeeking Alpha · 16 Sep 2026
- Alzamend Neuro Inc reports results for the quarter ended April 30 - Earnings SummaryReuters · 14 Sep 2026
- Alzamend Neuro Inc expected to post a loss of 23 cents a share - Earnings PreviewReuters · 11 Sep 2026
- ALZN: Net loss rose to $3.0 million as cash increased to $7.6 million, but funding risks persistQuartr · 10 Sep 2026
- Alzamend Neuro Inc expected to post a loss of 56 cents a share - Earnings PreviewReuters · 04 Sep 2026
- Alzamend Neuro Price Target Raised to $26.00/Share From $25.00 by Ascendiant CapitalDow Jones Newswires · 19 Aug 2026
- Alzamend Neuro Inc expected to post a loss of 67 cents a share - Earnings PreviewReuters · 24 Jul 2026
- ALZN: Net loss widened to $8.8M in FY26; urgent capital needs and going concern risk persistQuartr · 22 Jul 2026
Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.